| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/25/1997 | WO1997034631A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034617A1 Hla binding peptides and their uses |
| 09/25/1997 | WO1997034596A1 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases |
| 09/25/1997 | WO1997034589A1 Triaryl methane compounds for sickle cell disease |
| 09/25/1997 | WO1997034567A2 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/25/1997 | WO1997030704A3 Use of carbonic anhydrase inhibitors for treating macular edema |
| 09/25/1997 | WO1997027220A3 Substrates and inhibitors for cysteine protease ich-1 |
| 09/25/1997 | WO1997026867A3 Solid instant-release forms of administration and process for producing the same |
| 09/25/1997 | WO1997012043A3 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 09/25/1997 | CA2250016A1 Piperidine derivatives |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249739A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249465A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | CA2249401A1 Novel asymmetric synthesis of r-.alpha.-propyl-piperonyl amine and its analogs |
| 09/25/1997 | CA2249195A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | CA2248879A1 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases |
| 09/25/1997 | CA2248659A1 Hla binding peptides and their uses |
| 09/25/1997 | CA2247940A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 09/25/1997 | CA2220914A1 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/24/1997 | EP0796866A1 Antithrombotic diamides |
| 09/24/1997 | EP0796861A1 Silated derivatives of salicilic acid with desquamative properties |
| 09/24/1997 | EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists |
| 09/24/1997 | EP0796848A1 Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists |
| 09/24/1997 | EP0796609A2 Antialopecia agent |
| 09/24/1997 | EP0796331A2 Production and administration of high titer recombinant retroviruses |
| 09/24/1997 | EP0796325A1 Human vascular ibp-like growth factor |
| 09/24/1997 | EP0796321A1 E2 binding proteins |
| 09/24/1997 | EP0796320A1 Human dna ligase iii |
| 09/24/1997 | EP0796275A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 09/24/1997 | EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/24/1997 | EP0796258A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
| 09/24/1997 | EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0796100A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 09/24/1997 | EP0796097A1 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 09/24/1997 | EP0796096A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 09/24/1997 | EP0796093A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 09/24/1997 | EP0796092A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds |
| 09/24/1997 | EP0796091A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
| 09/24/1997 | EP0796080A1 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss |
| 09/24/1997 | EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 09/24/1997 | EP0617705B1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 09/24/1997 | EP0606463A4 Neuromedin b receptor antagonists. |
| 09/24/1997 | EP0491708B1 Isolating aminoarginine and use to block nitric oxide formation in body |
| 09/24/1997 | CN1160400A Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 09/24/1997 | CN1160352A Diazepino-indoles as phosphodiesterase IV inhibitors |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1160053A Process for preparation of enantiomerically pure imidazolyl compounds |
| 09/24/1997 | CN1160045A Matrix metalloprotease inhibitors |
| 09/24/1997 | CN1160042A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/24/1997 | CN1160041A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1159942A Placenta tonic and its processing and use |
| 09/24/1997 | CN1159929A Process for producing health Buthus martensi liquor |
| 09/24/1997 | CN1159919A Senility-proof health medicine |
| 09/24/1997 | CN1035939C Substd. (arylalkylaminobenzyl) aminopropionamide derivs., their preparation method |
| 09/24/1997 | CN1035925C Method for preparation of cytotropic non-homogeneous molecular lipid |
| 09/23/1997 | US5670699 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring |
| 09/23/1997 | US5670633 Sugar modified oligonucleotides that detect and modulate gene expression |
| 09/23/1997 | US5670619 Bradykinin-antagonists for the treatment of acute pancreatitis |
| 09/23/1997 | US5670538 Use of prodelphinidins for obtaining medicaments intended for the treatment of arthrosis |
| 09/23/1997 | US5670535 Thiophene compounds |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670522 Fused ring heterocycle, treatment of schizophrenia |
| 09/23/1997 | US5670516 Excitatory amino acid receptor antagonists |
| 09/23/1997 | US5670512 Skin disorders; reductase inhibitors |
| 09/23/1997 | US5670511 Indolepiperidine derivatives |
| 09/23/1997 | US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670503 Prophylactic and therapeutic treatment of interleukin-1 and tumor necrosis factor mediated diseases such as inflammatory diseases, autoimmune diseases |
| 09/23/1997 | US5670502 Method of tumor treatment |
| 09/23/1997 | US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents |
| 09/23/1997 | US5670494 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 09/23/1997 | US5670342 Stimulate the proliferation and differentiation of colon epithelial cells |
| 09/23/1997 | US5670338 Genetic engineering; therapy for osteoporosis |
| 09/23/1997 | US5670158 Bisacodyl dosage form |
| 09/23/1997 | CA2045857C Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase a2 inhibitor containing them |
| 09/22/1997 | CA2200163A1 Antithrombotic diamides |
| 09/20/1997 | CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/19/1997 | CA2199925A1 Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033993A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033887A1 Spirocycle integrin inhibitors |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/18/1997 | WO1997033882A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/18/1997 | WO1997033877A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 09/18/1997 | WO1997033856A1 Diaromatic propynyl or dienyl compounds |
| 09/18/1997 | WO1997033616A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | WO1997033608A2 Antagonism of endothelin actions |
| 09/18/1997 | WO1997033606A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
| 09/18/1997 | WO1997033588A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 09/18/1997 | WO1997033583A1 Methods of treating or preventing interstitial cystitis |
| 09/18/1997 | WO1997033552A1 Water soluble paclitaxel prodrugs |